{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "23536559",
  "DateCompleted": {
    "Year": "2014",
    "Month": "02",
    "Day": "20"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "12",
    "Day": "02"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2013",
        "Month": "03",
        "Day": "27"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1158/0008-5472.CAN-12-4576"
    ],
    "Journal": {
      "ISSN": "1538-7445",
      "JournalIssue": {
        "Volume": "73",
        "Issue": "16",
        "PubDate": {
          "Year": "2013",
          "Month": "Aug",
          "Day": "15"
        }
      },
      "Title": "Cancer research",
      "ISOAbbreviation": "Cancer Res"
    },
    "ArticleTitle": "The 19th annual Prostate Cancer Foundation scientific retreat.",
    "Pagination": {
      "StartPage": "4988",
      "EndPage": "4991",
      "MedlinePgn": "4988-91"
    },
    "Abstract": {
      "AbstractText": [
        "Prostate Cancer Foundation (PCF) convened its 19th Annual Scientific Retreat October 25-27, 2012, in Carlsbad, CA. Each year, this event brings together diverse researchers in a collaborative forum to present and discuss new and largely unpublished findings for prostate cancer diagnosis, prognosis, and treatment and defines the challenges to ending this disease as a threat to life and well-being. Several themes resonated at the multidisciplinary meeting, notably (i) the roles of field cancerization, tumor microenvironment, epithelial plasticity, signal transduction pathways in cancer progression, and disease resistance; (ii) intratumoral heterogeneity and consequences for precision medicine; (iii) resistance mechanisms to androgen axis inhibitors; and (iv) advances in molecular imaging and therapeutics for better detection and treatment."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Prostate Cancer Foundation, Santa Monica, CA 90401, USA."
          }
        ],
        "LastName": "Walia",
        "ForeName": "Guneet",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Pienta",
        "ForeName": "Kenneth J",
        "Initials": "KJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Simons",
        "ForeName": "Jonathan W",
        "Initials": "JW"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Soule",
        "ForeName": "Howard R",
        "Initials": "HR"
      }
    ],
    "PublicationTypeList": [
      "Congress"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Cancer Res",
    "NlmUniqueID": "2984705R",
    "ISSNLinking": "0008-5472"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prognosis"
    },
    {
      "QualifierName": [
        "drug therapy",
        "genetics",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Prostatic Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Signal Transduction"
    },
    {
      "QualifierName": [
        "drug effects",
        "genetics"
      ],
      "DescriptorName": "Tumor Microenvironment"
    }
  ]
}